206. Fragile X syndrome
98 clinical trials,   73 drugs   (DrugBank: 27 drugs),   46 drug target genes,   57 drug target pathways

Searched query = "Fragile X syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03624556
(ClinicalTrials.gov)
January 29, 20186/6/2018Pediatric Exploratory Research Study of EGCG Use and Safety (PERSEUS)Pediatric Exploratory Research Study of EGCG Use and Safety (PERSEUS)Down Syndrome;Fragile X SyndromeDietary Supplement: EGCG FontUp;Other: Placebo FontUpParc de Salut MarHospital Infantil Universitario Niño Jesús, Madrid, Spain;Instituto Hispalense de Pediatría, Sevilla, Spain;Hospital Universitario Marqués de Valdecilla;Institut Jerome LejeuneActive, not recruiting6 Years12 YearsAll70N/ASpain
2NCT01855971
(ClinicalTrials.gov)
June 11, 20139/5/2013Using Epigallocatechin Gallate (EGCG) and Cognitive Training to Modulate Cognitive Performance in Patients With Fragile X Syndrome (TESFX)Estrogen Receptors Beta (ER-B) as Therapeutic Targets for the Improvement of Cognitive Performance in Fragile-X (TESXF)Fragile X SyndromeDietary Supplement: EGCG;Dietary Supplement: Placebo;Other: Cognitive trainingParc de Salut MarNULLCompleted18 Years60 YearsAll44Phase 2Spain